INTELLECTIVE
LIVE

Serial Number

79378706

Owner

NaTurtle AG

Attorney

Stephanie Goeller

Filing Date

Jun 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

INTELLECTIVE Trademark

Serial Number: 79378706 • Registration: 7636717

INTELLECTIVE is a trademark filed by NaTurtle AG on June 13, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NaTurtle AG (2 trademarks)

Hagenholzstrasse 81a

Entity Type: 25

Intellective Biologics (Suzhou) Co., Ltd. (2 trademarks)

No. 96 Yinhe Road, Southeast Street

Entity Type: 99

Trademark Details

Filing Date

June 13, 2023

Registration Date

January 7, 2025

Published for Opposition

November 19, 2024

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; chemicals for use in industry and science; reagents for scientific apparatus for chemical or biological analyses being reagents for scientific and research use; protein in raw material form for scientific and medical research; biochemicals for in-vitro and in-vivo scientific use; biological preparations for use in industry and science; chemical preparations for use in industry; catalysts for chemical processes; diagnostic preparations for scientific use; diagnostic reagents for science or research use; stem cells for research purposes

Pharmaceutical products for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; medical preparations for the treatment of cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; veterinary preparations for vaccinating livestock; disinfectants; preparations for destroying vermin; fungicides; herbicides; dietetic food and beverages adapted for medical use; dietetic pet foods and beverages for veterinary use; food for babies; food supplements; medical plasters, medical dressings; medicines for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions

Research and development of new pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; providing information with respect to medical and scientific research in the field of pharmaceutical products; pharmaceutical research and development services; consultation with respect to pharmaceutical research; medical research; scientific research services for medical purposes in the field of pharmaceuticals; biomedical research services; scientific and medical research and development, namely, research and development in the field of medical preparations; design and development of testing and analysis methods for new pharmaceutical product development; scientific research in the nature of conducting clinical trials for others; analysis and evaluation of newly developed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; analysis and evaluation of newly designed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; stem cell research services; scientific research services for medical purposes in the field of proteins, antibodies, microorganisms and cells; product research; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing information on the results of clinical research trials for pharmaceutical products; consultation with respect to pharmaceutical research and development; providing integrated development of pharmaceutical products, namely, research and development of pharmaceutical products, and scientific research in the nature of conducting clinical trials and studies for others

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 26, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 5, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 5, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 7, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 12, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 16, 2024 TROA
REFUSAL PROCESSED BY IB
May 13, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 23, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 23, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 4, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 3, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Mar 30, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 5, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 4, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2024 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 10, 2023 ADCH
CHANGE OF OWNER RECEIVED FROM IB
Oct 27, 2023 CHLD
APPLICATION FILING RECEIPT MAILED
Sep 19, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 14, 2023 REPR